Table 33.4.
Postoperative wound infection—surgical site infections: international and Norwegian results
| Reference | Operation type | Year publ. | Total operated | Total % | Hip prothesis total | Hip prothesis partiell | CAGB sterum and donor | Cesarean section | Colon surgery | Cholesystectomi | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rosenthal et al.; INICC | More types | 2013 | 261,000 | 2,9 | 4,5 | 0,7 | 9,4 | 4 Continents | |||
| CDC-NHSN data, Edwards | More types | 2009 | 2,9 | 1,8 | 5,6 | USA | |||||
| Lissovy | More types | 2009 | 723,490 | 1 | 0 | 4,1 | 1,1 | USA 2005 | |||
| Mu, USAa | Many types | 2011 | 849,659 | 1,9 | 1,4 | 2,2 | 1,9 | 5,8 | 0,6 | USA Nationala | |
| Wilson 2007 | More types | 2007 | 111,360 | 1,6 | 4 | 3,7 | 2,7 | 8,9 | 1,3 | Europe 2004; HELICS | |
| Worth 2015 | More types | 2015 | 183,625 | 2,8 | 4,9 | 2 | 8,7 | Australia | |||
| Sherlaw-Johnson | CAGB | 2007 | 2146 | 11,9 | England | ||||||
| King | CAGB | 2014 | 303 | 6,6 | London | ||||||
| Wilson | Cesarean | 2013 | 4107 | 9,8 | UK | ||||||
| Calderwood | Hip prothesis | 2013 | 524,892 | 7,8 | Medicare, USA | ||||||
| Lindgren | Hip prothesis | 2014 | 45,531 | 0,9 | Sweden | ||||||
| Norway | |||||||||||
| Ullevål (Andersen) | All | 2009 | 12,430 | 6,2 | Prevalence Ullevål | ||||||
| National prevalence (FHI) | All | 2014 | ? | 7 | National Public Health | ||||||
| Flatmark | Colon surgery | 2000 | 100 | 8 | Lillehammer FSH | ||||||
| Dale H (1987–2011) | Hip prothesis | 2011 | 11,000 | 2,6 | 7,7 | Norwegian register | |||||
| Norway FHI—6 op. types | 6 types | 2011 | 6469 | 3,1 | 5,1 | 6,7 | 6,9 | 15,9 | 7,1 | Incidence 2011 | |
| Norway FHI—6 op. types | 6 types | 2013 | 29,016 | 2,2 | 3,9 | 3,6 | 4,2 | 13,5 | 4,5 | Incidence 2013 |
CABG, coronary artery bypass graft; ACB, artery coronary bypass. Ref. 100
aPrimary wound, only detected in hospital + readmitted same hospital